Synopsis
0
JDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Solubilizers
Surfactant & Foaming Agents
Emulsifying Agents
Thickeners and Stabilizers
Lubricants & Glidants
Parenteral
Granulation
Direct Compression
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ciclopirox Olamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciclopirox Olamine, including repackagers and relabelers. The FDA regulates Ciclopirox Olamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciclopirox Olamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ciclopirox Olamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ciclopirox Olamine supplier is an individual or a company that provides Ciclopirox Olamine active pharmaceutical ingredient (API) or Ciclopirox Olamine finished formulations upon request. The Ciclopirox Olamine suppliers may include Ciclopirox Olamine API manufacturers, exporters, distributors and traders.
click here to find a list of Ciclopirox Olamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ciclopirox Olamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Ciclopirox Olamine active pharmaceutical ingredient (API) in detail. Different forms of Ciclopirox Olamine DMFs exist exist since differing nations have different regulations, such as Ciclopirox Olamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ciclopirox Olamine DMF submitted to regulatory agencies in the US is known as a USDMF. Ciclopirox Olamine USDMF includes data on Ciclopirox Olamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ciclopirox Olamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ciclopirox Olamine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ciclopirox Olamine Drug Master File in Korea (Ciclopirox Olamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ciclopirox Olamine. The MFDS reviews the Ciclopirox Olamine KDMF as part of the drug registration process and uses the information provided in the Ciclopirox Olamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ciclopirox Olamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ciclopirox Olamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ciclopirox Olamine suppliers with KDMF on PharmaCompass.
A Ciclopirox Olamine CEP of the European Pharmacopoeia monograph is often referred to as a Ciclopirox Olamine Certificate of Suitability (COS). The purpose of a Ciclopirox Olamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ciclopirox Olamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ciclopirox Olamine to their clients by showing that a Ciclopirox Olamine CEP has been issued for it. The manufacturer submits a Ciclopirox Olamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ciclopirox Olamine CEP holder for the record. Additionally, the data presented in the Ciclopirox Olamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ciclopirox Olamine DMF.
A Ciclopirox Olamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ciclopirox Olamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ciclopirox Olamine suppliers with CEP (COS) on PharmaCompass.
A Ciclopirox Olamine written confirmation (Ciclopirox Olamine WC) is an official document issued by a regulatory agency to a Ciclopirox Olamine manufacturer, verifying that the manufacturing facility of a Ciclopirox Olamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ciclopirox Olamine APIs or Ciclopirox Olamine finished pharmaceutical products to another nation, regulatory agencies frequently require a Ciclopirox Olamine WC (written confirmation) as part of the regulatory process.
click here to find a list of Ciclopirox Olamine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ciclopirox Olamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ciclopirox Olamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ciclopirox Olamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ciclopirox Olamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ciclopirox Olamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ciclopirox Olamine suppliers with NDC on PharmaCompass.
Ciclopirox Olamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ciclopirox Olamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciclopirox Olamine GMP manufacturer or Ciclopirox Olamine GMP API supplier for your needs.
A Ciclopirox Olamine CoA (Certificate of Analysis) is a formal document that attests to Ciclopirox Olamine's compliance with Ciclopirox Olamine specifications and serves as a tool for batch-level quality control.
Ciclopirox Olamine CoA mostly includes findings from lab analyses of a specific batch. For each Ciclopirox Olamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ciclopirox Olamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciclopirox Olamine EP), Ciclopirox Olamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciclopirox Olamine USP).
LOOKING FOR A SUPPLIER?
